{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T18:48:16Z","timestamp":1772045296860,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.canrad.2023.06.008","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T04:07:10Z","timestamp":1689912430000},"page":"599-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Radiotherapy for rare primary brain tumors"],"prefix":"10.1016","volume":"27","author":[{"given":"E.","family":"Mesny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lesueur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2023.06.008_bib0560","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0565","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/cjn.2019.311","article-title":"Nervous system hemangiopericytoma","volume":"47","author":"Cohen-Inbar","year":"2020","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.canrad.2023.06.008_bib0570","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ijrobp.2012.05.042","article-title":"The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database","volume":"85","author":"Stessin","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib0575","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bpa.12613","article-title":"Grading of meningeal solitary fibrous tumors\/hemangiopericytomas: analysis of the prognostic value of the Marseille Grading System in a cohort of 132 patients","volume":"29","author":"Macagno","year":"2019","journal-title":"Brain Pathol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0580","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11060-018-2746-3","article-title":"Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma","volume":"137","author":"Jeon","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0585","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/cncr.21448","article-title":"Precision radiotherapy for hemangiopericytomas of the central nervous system","volume":"104","author":"Combs","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0590","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/TCRM.S375064","article-title":"Intracranial solitary fibrous tumor\/hemangiopericytoma treated with microsurgical resection: retrospective cohort analysis of a single-center experience","volume":"18","author":"Swaminathan","year":"2022","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.canrad.2023.06.008_bib0595","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4143\/crt.2021.142","article-title":"The role of postoperative radiotherapy in intracranial solitary fibrous tumor\/hemangiopericytoma: a multi-institutional retrospective study (KROG 18-11)","volume":"54","author":"Lee","year":"2022","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.canrad.2023.06.008_bib0600","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.wneu.2013.11.009","article-title":"Intracranial hemangiopericytoma\u2014our experience in 30 years: a series of 43 cases and review of the literature","volume":"81","author":"Melone","year":"2014","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0605","doi-asserted-by":"crossref","first-page":"2468320","DOI":"10.1155\/2020\/2468320","article-title":"Hemangiopericytoma: incidence, treatment, and prognosis analysis based on SEER database","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.canrad.2023.06.008_bib0610","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/COC.0000000000000146","article-title":"CNS Hemangiopericytoma: a systematic review of 523 patients","volume":"40","author":"Ghose","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0615","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3171\/2013.10.JNS13113","article-title":"The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a surveillance, epidemiology, and end results analysis","volume":"120","author":"Sonabend","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0620","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/j.wneu.2018.12.004","article-title":"Solitary fibrous tumor\/hemangiopericytoma of spinal cord: a retrospective single-center study of 16 cases","volume":"123","author":"Wang","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0625","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.3390\/cancers14122839","article-title":"Spinal solitary fibrous tumors: an original multicenter series and systematic review of presentation, management, and prognosis","volume":"14","author":"Apra","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2023.06.008_bib0630","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00701-016-2742-3","article-title":"The current role of Gamma Knife radiosurgery in the management of intracranial haemangiopericytoma","volume":"158","author":"Spina","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.canrad.2023.06.008_bib0635","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2008.03.024","article-title":"Adjuvant stereotactic radiosurgery after resection of intracranial hemangiopericytomas","volume":"72","author":"Kano","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib0640","doi-asserted-by":"crossref","first-page":"994335","DOI":"10.3389\/fonc.2022.994335","article-title":"Intracranial solitary fibrous tumor\/hemangiopericytoma: role and choice of postoperative radiotherapy techniques","volume":"12","author":"Gou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0645","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/neuonc\/noac188","article-title":"EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors","volume":"24","author":"Rud\u00e0","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0650","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ng.2682","article-title":"Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma","volume":"45","author":"Jones","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.canrad.2023.06.008_bib0655","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1002\/cncr.25988","article-title":"Upfront observation versus radiation for adult pilocytic astrocytoma","volume":"117","author":"Ishkanian","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0660","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial","volume":"366","author":"van den Bent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2023.06.008_bib0665","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ijrobp.2009.11.015","article-title":"Radiation therapy for pilocytic astrocytomas of childhood","volume":"79","author":"Mansur","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib0670","first-page":"199","article-title":"Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance)","volume":"2","author":"Brown","year":"2015","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.canrad.2023.06.008_bib0675","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cncr.24716","article-title":"The role of postoperative radiotherapy for the treatment of gangliogliomas","volume":"116","author":"Rades","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0680","first-page":"678","article-title":"Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database","volume":"19","author":"Terrier","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0685","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00381-018-3780-3","article-title":"Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma","volume":"34","author":"Mallick","year":"2018","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.canrad.2023.06.008_bib0690","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3171\/2012.7.JNS111260","article-title":"Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic","volume":"117","author":"Compton","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0695","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1606::AID-CNCR24>3.0.CO;2-B","article-title":"Central neurocytoma: histologic atypia, proliferation potential, and clinical outcome","volume":"85","author":"Mackenzie","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0700","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1212\/01.WNL.0000115392.21898.E3","article-title":"Prognostic value of the MIB-1 labeling index for central neurocytomas","volume":"62","author":"Rades","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.canrad.2023.06.008_bib0705","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/PAS.0b013e31823b8232","article-title":"Prognostic factors in central neurocytomas: a multicenter study of 71 cases","volume":"36","author":"Vasiljevic","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0710","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ijrobp.2006.10.018","article-title":"Central neurocytoma: management recommendations based on a 35-year experience","volume":"67","author":"Leenstra","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib0715","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/j.wneu.2020.01.114","article-title":"Central neurocytoma treatment modalities: a systematic review assessing the outcomes of combined maximal safe resection and radiotherapy with gross total resection","volume":"137","author":"Mahavadi","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0720","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clineuro.2013.11.028","article-title":"Intraventricular neurocytomas: a systematic review of stereotactic radiosurgery and fractionated conventional radiotherapy for residual or recurrent tumors","volume":"117","author":"Garcia","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0725","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14791\/btrt.2017.5.1.10","article-title":"Systematic analysis of clinical outcomes following stereotactic radiosurgery for central neurocytoma","volume":"5","author":"Bui","year":"2017","journal-title":"Brain Tumor Res Treat"},{"key":"10.1016\/j.canrad.2023.06.008_bib0730","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1215\/S1152851704000584","article-title":"Well-differentiated neurocytoma: what is the best available treatment?","volume":"7","author":"Rades","year":"2005","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0735","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11060-005-9047-3","article-title":"Treatment recommendations for the various subgroups of neurocytomas","volume":"77","author":"Rades","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0740","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2004.08.008","article-title":"Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas","volume":"74","author":"Rades","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0745","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3171\/2020.1.JNS191515","article-title":"Stereotactic radiosurgery for central neurocytomas: an international multicenter retrospective cohort study","volume":"134","author":"Hung","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0750","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cncr.20032","article-title":"Treatment of atypical neurocytomas","volume":"100","author":"Rades","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0755","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11060-008-9622-5","article-title":"Long-term outcome of conventional radiation therapy for central neurocytoma","volume":"90","author":"Paek","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0760","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10143-006-0024-x","article-title":"Central neurocytoma: a novel appraisal of a polymorphic pathology. Our experience and a review of the literature","volume":"29","author":"Lenzi","year":"2006","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.canrad.2023.06.008_bib0765","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/bpa.12639","article-title":"The genetic landscape of anaplastic pleomorphic xanthoastrocytoma","volume":"29","author":"Phillips","year":"2019","journal-title":"Brain Pathol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0770","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jocn.2018.05.003","article-title":"Grade II Pleomorphic Xanthoastrocytoma; a meta-analysis of data from previously reported 167 cases","volume":"54","author":"Mallick","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.canrad.2023.06.008_bib0775","doi-asserted-by":"crossref","first-page":"106042","DOI":"10.1016\/j.clineuro.2020.106042","article-title":"Association between adjuvant radiation therapy and overall survival in Pleomorphic Xanthoastrocytoma","volume":"196","author":"Khalafallah","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0780","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11060-017-2658-7","article-title":"Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma","volume":"136","author":"Tonse","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0785","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s11547-022-01531-3","article-title":"Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature","volume":"127","author":"Detti","year":"2022","journal-title":"Radiol Med"},{"key":"10.1016\/j.canrad.2023.06.008_bib0790","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2559.2007.02926.x","article-title":"Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types","volume":"52","author":"Hirose","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.canrad.2023.06.008_bib0795","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/cncr.26387","article-title":"Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs)","volume":"118","author":"Smoll","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0800","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1200\/JCO.2011.34.9373","article-title":"Adult medulloblastoma comprises three major molecular variants","volume":"29","author":"Remke","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0805","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S1470-2045(19)30669-2","article-title":"EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma","volume":"20","author":"Franceschi","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0810","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/jayao.2021.0034","article-title":"Clinical audit of survival outcomes and prognostic factors in adolescents and adults with medulloblastoma","volume":"11","author":"Patil","year":"2022","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0815","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11060-013-1327-8","article-title":"Adults with CNS primitive neuroectodermal tumors\/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol","volume":"116","author":"Friedrich","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0820","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11060-020-03564-y","article-title":"Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients","volume":"148","author":"Massimino","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0825","doi-asserted-by":"crossref","first-page":"9153496","DOI":"10.1155\/2018\/9153496","article-title":"Radiotherapy for adult medulloblastoma: evaluation of helical tomotherapy, volumetric intensity modulated arc therapy, and three-dimensional conformal radiotherapy and the results of helical tomotherapy therapy","volume":"2018","author":"Zong-Wen","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.canrad.2023.06.008_bib0830","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ijrobp.2009.09.020","article-title":"Standard and nonstandard craniospinal radiotherapy using helical TomoTherapy","volume":"77","author":"Parker","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib0835","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1002\/cncr.31575","article-title":"Quality of life in patients with proton-treated pediatric medulloblastoma: results of a prospective assessment with 5-year follow-up","volume":"124","author":"Kamran","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0840","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-021-03863-y","article-title":"Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade","volume":"155","author":"Lu","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0845","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.3390\/cancers14153646","article-title":"Diagnosis and treatment of pineal region tumors in adults: a EURACAN overview","volume":"14","author":"Lombardi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2023.06.008_bib0850","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/neuonc\/noab252","article-title":"EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults","volume":"24","author":"Frappaz","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0855","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1200\/JCO.1999.17.8.2585","article-title":"Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83\/86\/89","volume":"17","author":"Bamberg","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0860","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/neuonc\/not019","volume":"15","author":"Calaminus","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0865","first-page":"1318","article-title":"Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience","volume":"12","author":"Alapetite","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0870","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejca.2020.06.012","article-title":"Relapsing intracranial germ cell tumours warrant retreatment","volume":"136","author":"Callec","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0875","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.30755","article-title":"Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy","volume":"141","author":"Murray","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0880","first-page":"i56","article-title":"GCT-12. SIOP CNS GCT II: High Risk (HR) CNS Non-germinomatous Germ Cell Tumours (NGGCT) treated with Dose intensified PEI\u2013final results","volume":"24","author":"Calaminus","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0885","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.ijrobp.2012.02.033","article-title":"Potential for improved intelligence quotient using volumetric modulated arc therapy compared with conventional 3-dimensional conformal radiation for whole-ventricular radiation in children","volume":"84","author":"Qi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib0890","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-015-0441-5","article-title":"Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors","volume":"10","author":"Park","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0895","first-page":"53","article-title":"Whole-ventricular irradiation for intracranial germ cell tumors: dosimetric comparison of pencil beam scanned protons, intensity-modulated radiotherapy and volumetric-modulated arc therapy","volume":"15","author":"Correia","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0900","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/neuonc\/nox122","article-title":"Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial","volume":"19","author":"Calaminus","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0905","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1200\/JCO.19.00701","article-title":"Phase II trial of response-based radiation therapy for patients with localized CNS nongerminomatous germ cell tumors: a children's Oncology Group Study","volume":"37","author":"Fangusaro","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0910","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2014.59.5132","article-title":"Phase II trial assessing the ability of neoadjuvant chemotherapy with or without second-look surgery to eliminate measurable disease for nongerminomatous germ cell tumors: a children's Oncology Group Study","volume":"33","author":"Goldman","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0915","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3171\/2009.12.JNS091683","article-title":"Tumor control after surgery and radiotherapy for pineocytoma","volume":"113","author":"Clark","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0920","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.radonc.2016.10.025","article-title":"Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis","volume":"121","author":"Mallick","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0925","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4103\/0028-3886.329550","article-title":"Pineal Parenchymal Tumor of Intermediate Differentiation (PPTID) and Papillary Tumor of Pineal Region (PTPR): a review","volume":"69","author":"Sadashiva","year":"2021","journal-title":"Neurol India"},{"key":"10.1016\/j.canrad.2023.06.008_bib0930","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10143-021-01674-3","article-title":"Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades","volume":"45","author":"Takase","year":"2022","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.canrad.2023.06.008_bib0935","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-013-1050-5","article-title":"Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region: a multicenter study","volume":"112","author":"Fauchon","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0940","doi-asserted-by":"crossref","first-page":"E420","DOI":"10.1093\/neuros\/nyz062","article-title":"Papillary tumor of the pineal region: systematic review and analysis of prognostic factors","volume":"85","author":"Yamaki","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2023.06.008_bib0945","doi-asserted-by":"crossref","first-page":"105646","DOI":"10.1016\/j.clineuro.2019.105646","article-title":"Radiotherapy for papillary tumor of the pineal region: a systematic review of the literature","volume":"190","author":"Lancia","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib0950","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cncr.26300","article-title":"The long-term postsurgical prognosis of patients with pineoblastoma","volume":"118","author":"Tate","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.008_bib0955","first-page":"576","article-title":"Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data","volume":"19","author":"Mynarek","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0960","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fonc.2020.01021","article-title":"Development and validation of a prognostic nomogram to predict cancer-specific survival in adult patients with pineoblastoma","volume":"10","author":"Jing","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0965","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0970","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/neuonc\/nox166","article-title":"EANO guidelines for the diagnosis and treatment of ependymal tumors","volume":"20","author":"Rud\u00e0","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0975","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/brain\/awm046","article-title":"Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients","volume":"130","author":"Metellus","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.canrad.2023.06.008_bib0980","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ijrobp.2007.12.036","article-title":"Influence of radiotherapy treatment concept on the outcome of patients with localized ependymomas","volume":"71","author":"Combs","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib0985","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2020.05.045","article-title":"Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: an intergroup collaborative study (KROG 18-06\/KNOG 18-01)","volume":"150","author":"Wee","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib0990","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijrobp.2004.06.002","article-title":"Postoperative radiation therapy for grade II and III intracranial ependymoma","volume":"61","author":"Mansur","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib0995","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11060-013-1254-8","article-title":"Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis","volume":"115","author":"Ghia","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1000","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1179\/1743132815Y.0000000041","article-title":"Predictors of survival in patients with spinal ependymoma","volume":"37","author":"Lin","year":"2015","journal-title":"Neurol Res"},{"key":"10.1016\/j.canrad.2023.06.008_bib1005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/neuonc\/nos286","article-title":"Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas","volume":"15","author":"Oh","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3171\/2013.6.SPINE12927","article-title":"Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review","volume":"19","author":"Feldman","year":"2013","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.canrad.2023.06.008_bib1015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-006-9169-2","article-title":"Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center","volume":"80","author":"Akyurek","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2007.11.058","article-title":"Intensity-modulated radiation therapy in childhood ependymoma","volume":"71","author":"Schroeder","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2023.02.020","article-title":"Prognostic factors and treatment impact on overall survival in adult craniopharyngioma","author":"Awad","year":"2023","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib1030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jss.2018.01.029","article-title":"Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis","volume":"226","author":"Wang","year":"2018","journal-title":"J Surg Res"},{"key":"10.1016\/j.canrad.2023.06.008_bib1035","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2012-3928","article-title":"Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity","volume":"98","author":"Elowe-Gruau","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2023.06.008_bib1040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-012-0806-7","article-title":"The superiority of conservative resection and adjuvant radiation for craniopharyngiomas","volume":"108","author":"Schoenfeld","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11060-022-03983-z","article-title":"Disease control after radiotherapy for adult craniopharyngioma: clinical outcomes from a large single-institution series","volume":"157","author":"Rutenberg","year":"2022","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1050","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ijrobp.2021.02.045","article-title":"Proton radiation therapy for pediatric craniopharyngioma","volume":"110","author":"Jimenez","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib1055","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/neuonc\/noac210","article-title":"Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients","volume":"25","author":"Beddok","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11060-011-0693-3","article-title":"Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma","volume":"106","author":"Iwata","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11102-018-0903-5","article-title":"Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma","volume":"21","author":"Losa","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.canrad.2023.06.008_bib1070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2009.07.1693","article-title":"Radiosurgery for craniopharyngioma","volume":"78","author":"Niranjan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib1075","doi-asserted-by":"crossref","first-page":"882381","DOI":"10.3389\/fendo.2022.882381","article-title":"Neoadjuvant B-RAF and MEK Inhibitor targeted therapy for adult papillary craniopharyngiomas: a new treatment paradigm","volume":"13","author":"Calvanese","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.canrad.2023.06.008_bib1080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/0284186X.2012.685525","article-title":"Long-term outcomes for adult craniopharyngioma following radiation therapy","volume":"52","author":"Masson-Cote","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1085","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.ijrobp.2012.10.030","article-title":"Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma","volume":"85","author":"Merchant","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.008_bib1090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2020.11.014","article-title":"ESTRO ACROP guideline for target volume delineation of skull base tumors","volume":"156","author":"Combs","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1095","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1016\/j.wneu.2020.05.258","article-title":"Utility of interval imaging during focused radiation therapy for residual cystic craniopharyngiomas","volume":"141","author":"Moorthy","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.canrad.2023.06.008_bib1100","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.radonc.2016.12.033","article-title":"Challenges and opportunities in primary CNS lymphoma: a systematic review","volume":"122","author":"Kerbauy","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1105","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","article-title":"Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome","volume":"31","author":"Morris","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.008_bib1110","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1182\/bloodadvances.2022007011","article-title":"Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study","volume":"6","author":"Lesueur","year":"2022","journal-title":"Blood Adv"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182300121X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182300121X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:37:43Z","timestamp":1761136663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832182300121X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":111,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S127832182300121X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2023.06.008","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for rare primary brain tumors","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2023.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}